Summary

Much investigation is ongoing to improve monitoring and therapeutic options for acute respiratory distress syndrome (ARDS), with more than 300 trials currently underway. This article discusses specific areas of research that are likely to shape our understanding and treatment of ARDS over the next 10 years.